Process indicators to monitor pre-treatment linkage to care and treatment among patients diagnosed with rifampicin-resistant tuberculosis in Johannesburg, South Africa

By  Idah Mokhele  A. AndrĂ©asson  E. Madibogo  N. Ndjeka  J. Farley  E. Lönnermark  Dr. Denise Evans  |  | 

Pre-treatment death and loss-to-follow-up remained unaffected over the years (p>0.05); however, the proportion of untraceable patients was significantly lower after 2017 (<6%) compared to 10-15% in previous years. After 2017, there was a sustained increase in those successfully traced and referred for treatment (>75% of diagnosed), and those successfully linked to care.

Compared to prior years, mean time from specimen collection to when the sub-district was notified significantly decreased between 2018 2020 (83.5 vs 82.5 vs 64.9 days, respectively). Time between notification and treatment initiation more than halved in 2017 and 2018 compared to 2015 and 2016. Reduction in the time to RR-TB diagnosis and a shorter turnaround time to refer patients resulted in a similar decrease in time to treatment initiation after 2018.

Publication details